Accession | ARO:3004204 |
Definition | EBR beta-lactamases are Class B beta-lactamases first isolated from Empedobacter brevis and are able to hydrolyze penicillins, cephalosporins, and carbapenems. |
Drug Class | carbapenem, cephalosporin, penam |
Resistance Mechanism | antibiotic inactivation |
Classification | 12 ontology terms | Show + process or component of antibiotic biology or chemistry + mechanism of antibiotic resistance + determinant of antibiotic resistance + antibiotic inactivation [Resistance Mechanism] + antibiotic inactivation enzyme + hydrolysis of antibiotic conferring resistance + antibiotic molecule + hydrolysis of beta-lactam antibiotic by metallo-beta-lactamase + beta-lactam antibiotic + beta-lactamase + cephem + class B (metallo-) beta-lactamase |
Parent Term(s) | 4 ontology terms | Show + confers_resistance_to_drug_class carbapenem [Drug Class] + confers_resistance_to_drug_class cephalosporin [Drug Class] + confers_resistance_to_drug_class penam [Drug Class] + subclass B1 (metallo-) beta-lactamase |
Sub-Term(s) | 5 ontology terms | Show |
Publications | Bellais S, et al. 2002. Antimicrob Agents Chemother 46(10): 3223-3227. EBR-1, a novel Ambler subclass B1 beta-lactamase from Empedobacter brevis. (PMID 12234848) |